This is a preview of subscription content, log in via an institution to check access.
Notes
The study was funded by Eli Lilly and Company.
Reference
Edson-Heredia E, et al. Real-World Claims Analyses of Comorbidity Burden, Treatment Pattern, Healthcare Resource Utilization, and Costs in Pediatric Psoriasis. Advances in Therapy : 6 Jun 2021. Available from: URL: http://doi.org/10.1007/s12325-021-01795-7
Rights and permissions
About this article
Cite this article
Paediatric psoriasis: higher comorbidity and healthcare cost burden by severity. PharmacoEcon Outcomes News 881, 25 (2021). https://doi.org/10.1007/s40274-021-7821-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7821-x